O'Dell Group’s Novo Nordisk NVO Stock Holding History

O'Dell Group’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,881	Closed	-$224K	–	110
2024 Q3	$224K	Buy	+1,881	New	+$251K	0.05%	90
2024 Q1	–	Sell	-228	Closed	-$23.6K	–	353
2023 Q4	$23.6K	Buy	+228	New	+$22.5K	0.01%	273
2023 Q3	–	Sell	-90	Closed	-$7.28K	–	345
2023 Q2	$7.28K	Buy	+90	New	+$7.35K	﹤0.01%	368
2022 Q2	–	Sell	-124	Closed	-$7K	–	527
2022 Q1	$7K	Hold	124	–	–	﹤0.01%	349
2021 Q4	$7K	Hold	124	–	–	﹤0.01%	345
2021 Q3	$6K	Buy	+124	New	+$6K	﹤0.01%	355

Other funds holding NVO

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

O'Dell Group's NVO Position: Q4 2024 in Review

O'Dell Group sold out of Novo Nordisk (NVO) in Q4 2024, closing a stake of 1,881 shares — an estimated $224K sold.

O'Dell Group first reported a position in NVO in Q3 2021 and held it in 6 quarters. The position peaked at $224K in Q3 2024. 1,665 funds tracked by Wall St. Rank hold NVO as of Q4 2024.

O'Dell Group reported no remaining Novo Nordisk position as of Q4 2024 after selling out during the quarter.
O'Dell Group sold 1,881 Novo Nordisk shares in Q4 2024, an estimated $224K.
O'Dell Group first reported a position in Novo Nordisk in Q3 2021 and held it in 6 quarters.
O'Dell Group's Novo Nordisk position peaked at $224K in Q3 2024.
1,665 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2024.

Based on O'Dell Group's 13F filing for Q4 2024, filed 7 Feb 2025.